United States News All stories

Atour Lifestyle Holdings (NASDAQ:ATAT) reported a robust start to fiscal year 2026, delivering triple-digit profit momentum and aggressive top-line growth.

National Vision Holdings (NASDAQ:EYE) delivered a sharp increase in profitability for the first quarter of 2026, as successful pricing initiatives and a shift toward managed care customers bolstered the company’s bottom line.

Boyd Group Services (NYSE:BGSI) delivered record-breaking financial results for the first quarter of 2026, as the company reaped the initial benefits of its transformative $1.3 billion acquisition of Joe Hudson’s Collision Center.

Regis Corporation (NASDAQ:RGS) demonstrated improved operational efficiency in its third fiscal quarter, reporting a significant rise in net income and earnings per share despite a contraction in its top-line revenue.

WeRide (NASDAQ:WRD) reported record unaudited financial results for the first quarter of 2026, as the company’s aggressive international expansion into fare-charging robotaxi services began to scale.

Birkenstock Holding (NYSE:BIRK) revealed a surge in quarterly sales that matched its aggressive growth ambitions, though bottom-line results were pinched by escalating trade costs and unfavorable currency movements.

Alibaba Group Holding (NYSE:BABA) reported a complex set of financial results for the quarter and fiscal year ended March 31, 2026, revealing a company in the midst of an expensive strategic pivot.

UCloudlink Group (NASDAQ:UCL) recorded a contraction in its financial performance for the first quarter of 2026, marked by declining top-line revenue and a return to negative adjusted earnings.

Kyivstar (NASDAQ:KYIV) reported a robust start to fiscal year 2026, characterized by a significant acceleration in digital service adoption and strong double-digit growth across its core financial metrics.

Takeda Pharmaceutical (NYSE:TAK) reported fiscal year 2025 results that met its revised management guidance, as the company utilized aggressive operational savings to buffer the impact of generic competition for its top-selling ADHD medication, Vyvanse.

Innate Pharma (NASDAQ:IPHA), a clinical-stage biotechnology company specializing in immuno-oncology, announced its business update and consolidated financial results for the quarter ended March 31, 2026.

TORM (NASDAQ:TRMD) revealed a surge in first-quarter earnings as geopolitical volatility and the closure of the Strait of Hormuz drove global freight rates to record levels.

ICL Group (NYSE:ICL) raised its full-year profit outlook on Wednesday after reporting a double-digit increase in first-quarter earnings, buoyed by higher prices for bromine and potash.

Flex LNG (NYSE:FLNG) reported a sequential decline in earnings for the first quarter of 2026, reflecting a typical seasonal softening in the liquefied natural gas shipping market.

Wix.com (NASDAQ:WIX) reported a 14% increase in first-quarter revenue to $541.2 million, as the company aggressively pivots toward proprietary artificial intelligence and capital consolidation.

B&G Foods (NYSE:BGS) reported a net loss for the first quarter of 2026 as the company accelerated a major overhaul of its brand portfolio, headlined by the exit from the Green Giant U.S. frozen business.

Alphabet's (NASDAQ:GOOGL) Google is in discussions with Elon Musk’s SpaceX for a rocket launch agreement to deploy a network of orbital data centers, according to people familiar with the matter.

IHS Holding (NYSE:IHS), one of the world's largest independent telecommunications infrastructure developers, reported a 6% increase in first-quarter revenue from continuing operations, as favorable foreign exchange movements masked a slight decline in organic growth.

Tencent Music (NYSE:TME) delivered total net revenues of RMB 7.90 billion ($1.15 billion) for the quarter ended March 31, 2026.

QXO (NYSE:QXO) reported first-quarter 2026 financial results that reflected broader cooling in the building products industry, alongside the impact of aggressive investments in the company’s buy-and-build strategy.

Kura Oncology (NASDAQ:KURA) reported $5.8 million in net product revenue for the first quarter of 2026, marking the first full period of sales for its acute myeloid leukemia treatment, Komzifti.

PACS Group (NYSE:PACS) delivered a dominant first quarter for 2026, reporting an 11.2% revenue increase and a nearly threefold jump in net income.

C3.ai (NYSE:AI), the enterprise AI application software company, today announced preliminary financial results for its fourth quarter and full fiscal year ended April 30, 2026, along with significant changes to its executive leadership.

Allot (NASDAQ:ALLT) reached a significant financial turning point in the first quarter of 2026, swinging to a GAAP profit as its transition toward a subscription-based security model gained momentum.